Concepedia

Publication | Open Access

Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: The FIDELIO-DKD Subgroup from China

19

Citations

21

References

2023

Year

Abstract

Finerenone resulted in lower risks of CKD progression than placebo and a balanced safety profile in Chinese patients with CKD and T2DM.

References

YearCitations

Page 1